Abstract:Abstract Background Combined pulmonary fibrosis and emphysema (CPFE) is a heterogeneous clinico-radiological syndrome without a consensus definition. There are limited data on the relation between the amount of parenchymal fibrosis and prognosis. In this study, we assessed the prognostic implications of the extent of fibrosis assessed by an automated quantitative computed tomography (CT) technique and the radiological and functional change over time in patients with a broad spectrum of fibrotic interstitial lung diseases (ILDs) encountered in a real-world setting. Methods We conducted a single-centre, retrospective study of 228 consecutive patients with CPFE, encountered from 2007 to 2015 at Kameda Medical Center, Chiba, Japan. We investigated the prognostic value of automated CT fibrosis quantification and the subsequent course of CPFE. Results Among 228 patients with CPFE, 89 had fibrosis affecting < 5% of their lungs, 54 had 5 to < 10% fibrosis, and 85 had ≥ 10% fibrosis at the time of diagnosis. Lower volume of fibrosis correlated with lower rates of mortality and acute exacerbation ( p < 0.001). In particular, among those with < 5% fibrosis, only 4.5% died and none experienced acute exacerbation during follow-up, whereas 57.6% and 29.4% of those with ≥ 10% fibrosis experienced death and acute exacerbation, respectively. Although, the ≥ 10% fibrosis group had the poorest overall survival as well as the highest incidence of acute exacerbation, the incidence of decline in pulmonary function tests, change per year in total lung volume, and progression of fibrosis on chest CT was highest in the 5 to < 10% fibrosis group. The Cox proportional hazard model for CPFE progression (defined by composite criteria of death, acute exacerbation, and decline in forced vital capacity or diffusing capacity) showed fibrosis proportion was a risk factor independent of age, sex, smoking pack-years, the Charlson Comorbidity Index, lung cancer, connective tissue disease, and idiopathic pulmonary fibrosis. Conclusions Less severe (< 5%) fibrosis at baseline was associated with disease stability and better prognosis compared to more severe fibrosis in CPFE occurring with fibrotic ILDs. Further studies including a validation cohort will be needed. Trial Registration Retrospectively registered.

Interpretation of the " Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement" : Clinical, imaging, pathological findings and relevant terms

Combined Pulmonary Fibrosis and Emphysema: A Narrative Review

Combined Pulmonary Fibrosis and Emphysema Syndrome

Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis

Quantitative Imaging Methods in Combined Pulmonary Fibrosis and Emphysema

Towards a refined definition of combined pulmonary fibrosis and emphysema

Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema Revisited with the 2015 World Health Organization Classification of Lung Tumors.

Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis

Computed Tomography Characterization of Emphysema in Combined Pulmonary Fibrosis and Emphysema (CPFE) and Its Correlation with Lung Cancer with Comparison to Chronic Obstructive Pulmanory Disease (COPD)

Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management

Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.

Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease

Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation

Progressive pulmonary fibrosis: an expert group consensus statement

Meta-analysis: clinical features and treatments of lung cancer in combined pulmonary fibrosis and emphysema

Interpretation of the Lancet Commission on Towards the Elimination of Chronic Obstructive Pulmonary Disease: New Definition and Recommendations for Clinical Management of Chronic Obstructive Pulmonary Disease

Analysis of clinical characteristics and prognosis of lung cancer patients with CPFE or COPD: a retrospective study

Explicate molecular landscape of combined pulmonary fibrosis and emphysema through explainable artificial intelligence: a comprehensive analysis of ILD and COPD interactions using RNA from whole lung homogenates

Combined pulmonary fibrosis and emphysema and lung transplantation: current evidence and future directions

Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE)